Evidence map›Paper›PMID 42410656›Full record

ArticleJournal of neuroinflammation2026

The Wiskott-Aldrich Syndrome protein (WASp) contribution to microglial phagocytic function and neurodevelopmental support.

Serena Seminara, Aurora Bianchi, Davide Comolli, Marco Spreafico, Wenjie Liao, Hemanta Sarmah, Grazia Iannello, Barbara Corneo, Gianluigi Forloni, Elisa R Zanier and 3 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Serena Seminara *Laboratory of Stroke and Vascular Dysfunctions, Department of Acute Brain and Cardiovascular Injury, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, Milan, 20156, Italy.
Aurora Bianchi *Laboratory of Stroke and Vascular Dysfunctions, Department of Acute Brain and Cardiovascular Injury, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, Milan, 20156, Italy.
Davide ComolliLaboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Marco SpreaficoLaboratory of Vascular Physiology, Department of Biosciences, University of Milan, Via G. Celoria 26, Milan, 20133, Italy.
Wenjie LiaoLaboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Hemanta SarmahColumbia Stem Cell Initiative, Stem Cell Core, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Grazia IannelloColumbia Stem Cell Initiative, Stem Cell Core, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Barbara CorneoColumbia Stem Cell Initiative, Stem Cell Core, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Gianluigi ForloniLaboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Elisa R ZanierLaboratory of Traumatic Brain Injury and Neuroprotection, Department of Acute Brain and Cardiovascular Injury, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Massimiliano De PaolaLaboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Alessandro FantinLaboratory of Vascular Physiology, Department of Biosciences, University of Milan, Via G. Celoria 26, Milan, 20133, Italy. alessandro.fantin@unimi.it.
Stefano FumagalliLaboratory of Stroke and Vascular Dysfunctions, Department of Acute Brain and Cardiovascular Injury, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, via Mario Negri 2, Milan, 20156, Italy. stefano.fumagalli@marionegri.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid progenitor cells colonize the brain during embryogenesis and differentiate in microglia. Microglia shape neuronal wiring during development and maintain brain homeostasis in adulthood, both actions requiring intact cytoskeletal functionality. The Wiskott-Aldrich syndrome protein (WASp) mediates cytoskeletal dynamics of peripheral myeloid cells, suggesting a similar role in microglia. To investigate WASp's role in microglia, we impaired WASp function in human induced pluripotent stem cells-derived microglia (iMicro) and zebrafish embryos.WASp colocalized with the actin cytoskeleton at membrane ruffles in phagocytic iMicro and appeared required for their phagocytic function. When co-cultured with neuronal cells, the support of iMicro with defective WASp function to neuronal wiring was impaired. Similarly, zebrafish embryos exposed to WASp inhibition showed brain accumulation of uncleared apoptotic bodies, reduced brain colonization of myeloid cells, and impaired sensorimotor response to mechanical stimuli.These findings identify WASp as a regulator of microglial phagocytosis and cytoskeletal dynamics, with implication in neuronal wiring during neurodevelopment.

Indexed as

MicrogliaPhagocytosisWiskott-Aldrich Syndrome ProteinAnimalsAnimals, Genetically ModifiedBrainCells, CulturedCoculture TechniquesEmbryo, NonmammalianHumansNeurodevelopmentNeuronsZebrafishWiskott-Aldrich Syndrome ProteinMicrogliaNeurodevelopmentPrimary immunodeficiencyWiskott-Aldrich Syndrome protein (WASp)

Identifiers

PMID42410656
PMCPMC13621662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.